Cyber Knife Market Scope
The CyberKnife System is a revolutionary radio surgical device manufactured by Accuray Incorporated that uses a combination of robotics and sophisticated image-guidance technology. The system is designed for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system is also used to select 3D conformal radiotherapy (3D-CRT) and intensity-modulated radiation therapy (IMRT). It is an innovative, effective, frameless, non-invasive substitute used for the treatment of both cancerous and non-cancerous tumors, intracranial lesions, tumors of lung, spine, prostate, and kidney, recurrent cases of oral squamous cell carcinoma, arteriovenous malformation, and trigeminal neuralgia. The Asia Pacific is the fastest-growing market of radiation therapy with countries like China and India are adopting this technology at a broader level.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Accuray Incorporated (United States), BrainLab (Germany), Elekta AB (Sweden), GE Healthcare (United States), Hitachi America (United States), IBA Group (Czech Republic), Mitsubishi Electric (Japan), Nordion (Canada), Philips Healthcare (The Netherlands) and RaySearch (Sweden) |
CAGR | % |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Cyber Knife market throughout the predicted period.
Accuray Incorporated (United States), BrainLab (Germany), Elekta AB (Sweden), GE Healthcare (United States), Hitachi America (United States), IBA Group (Czech Republic), Mitsubishi Electric (Japan), Nordion (Canada), Philips Healthcare (The Netherlands) and RaySearch (Sweden) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Sumitomo Heavy Industries (Japan) and Varian Medical Systems (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Cyber Knife market by Type , by Application (Intracranial & Spinal Applications, Extracranial Applications and Others) and Region with country level break-up.
On the basis of geography, the market of Cyber Knife has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2022.
Market Leaders and their expansionary development strategies
In August 2023, Varian Medical Systems announced a partnership with Elekta AB to develop and manufacture next-generation cyber knife systems. The two companies will combine their expertise to develop new systems that are more efficient, effective, and affordable.
In October 2023, Accuray Incorporated announced the launch of its next-generation CyberKnife® Robotic Radiosurgery System. The new system features a number of improvements, including a faster delivery system, a more precise targeting system, and a more comfortable patient experience.
The CyberKnife Robotic Radiosurgery System was cleared by the US Food and Drug Administration (FDA) in 1999 to treat tumors in the head and base of the skull. The CyberKnife System is not a surgical procedure. The CyberKnife System delivers high doses of pin-point radiation directly to head and neck cancers.
Influencing Trend:
A Significant Expansion of Treatment Configurations Utilizing Intelligent Robotics and Precision Radiosurgery with Mobility and Painless Treatment
Market Growth Drivers:
The growing number of intracranial, spinal, and extracranial diseases such as tumors, cancer and lung diseases in people, is the key driving factor for the growth of the market. and Rise in Number Geriatric Population around the Globe
Challenges:
Stringent Government Regulation and Huge Investments in Research and Development
Restraints:
Requirement of Radiation Oncologists, Medical Physicists, and Technologists for the Successful Outcome of Treatment, Longer Treatment Time and Negligence Can Result in Death of Patient owing to Delivery of High Dose of Radiations
Opportunities:
The Technological Advancements in Stereotactic Neurosurgery, By Use of An Optimized Path Traversal Process, The Overall Treatment Time can be reduced by 5-10 Min and Effective Substitute for Chemotherapy
Key Target Audience
Hospitals and Clinics, Research Organization and Institutes and Industrial Bodies and Associations